Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Active substance factsheet - Last updated: 08/07/2020

Active substance

Substance name:

.alpha.-cyano-3-phenoxybenzyl2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin)

EC number:

-; 254-484-5

CAS number:

39515-40-7

IUPAC name:

cyano(3-phenoxyphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate

BAS number:

1284

Product-type:

PT18

Candidate for substitution:

Yes

Regulatory Process:

Review programme substance

Approval/Assessment status:

Approved

Related authorised biocidal products

No related authorised products are available

Approval data details
Administrative identifiers

Evaluating competent authority:

Greece

R4BP asset number:

EU-0018404-0000

Approval identifiers

Legal act:

Reg (EU) 2018/1292

Validity of approval

Start date:

01/02/2020

End date:

31/01/2030

Documents
Assessment Reports

Assessment Report

Cyphenothrin_PT18_Assessment_Report.pdf (en)

Study summaries (Document III-A)
Other documents

BPC opinions

Cyphenothrin_PT 18_ Final_BPC opinion.pdf (en)

Amendment of active substance - Conclusion Date: 11/03/2020
Assessment information

Evaluating competent authority:

European Commission

Assessment outcome:

Successful

Conclusion date:

11/03/2020

Validity of approval

Start date:

01/02/2020

End date:

31/01/2030

Legal act:

Reg (EU) 2018/1292

Documents
Assessment Reports

Assessment Report

Cyphenothrin_PT18_Assessment_Report.pdf (en)

Study summaries (Document III-A)
Other documents

BPC opinions

Cyphenothrin_PT 18_ Final_BPC opinion.pdf (en)

Amendment of active substance - Conclusion Date: 06/02/2019
Assessment information

Evaluating competent authority:

European Commission

Assessment outcome:

Successful

Conclusion date:

06/02/2019

Validity of approval

Start date:

01/02/2020

End date:

31/01/2030

Legal act:

Reg (EU) 2018/1292

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents

BPC opinions

Cyphenothrin_PT 18_ Final_BPC opinion.pdf (en)

Approval of active substance - Conclusion Date: 09/10/2018
Assessment information

Evaluating competent authority:

Greece

Assessment outcome:

Successful

Conclusion date:

09/10/2018

Validity of approval

Start date:

01/02/2020

End date:

31/01/2030

Legal act:

Reg (EU) 2018/1292

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents